OVERVIEW
Listen to the Conference Chairs Discuss Highlights from WCLC 2020.

In this live webinar Dr. Yi-long Wu, Dr. Daniel Tan and Dr. Ross Soo will discuss key abstracts, presentations, and developments reported during the 2020 World Conference on Lung Cancer Singapore. This webinar is designed to meet the educational needs of researchers and healthcare professionals who diagnose and treat patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists, advanced practice nurses, and physician assistants.

Daniel Tan:

Advisory Board: Novartis, Bayer, Boehringer Ingelheim, Astra Zeneca, Eli-lily, Loxo, Pfizer, MSD. Contracted/Support research grant: Novartis, Astra Zeneca, GlaxoSmithKline, Bayer, Pfizer.

Yi-long Wu:

Advisory Board: AstraZeneca, Boehringer Ingelheim. Honorarium received from promotional activities: AstraZeneca, Roche, Boehringer Ingelheim, Pfizer, BMS, MSD, Eli Lilly (all not promotional activities). Contracted/Support Research Grant: AstraZeneca, Roche, Boehringer Ingelheim.

Ross Soo:

Contracted/Support research grant: AstraZeneca, and Boehringer Ingelheim. Personal fees: Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer,Roche, Taiho, Takeda, Yuhan, Amgen.

None of the other individuals involved in the planning or review of the activity have disclosed any relevant financial relationships.

At the conclusion of this activity, participants will be able to:
Describe scientific progress in the prevention, early detection, diagnosis and treatment of thoracic malignancies.
Explain advances in the multidisciplinary management of patients in relation to current standards of care.
Identify the most relevant clinical research results and ongoing trials likely to impact patient care in the near future.